Penumbral Rescue by Normobaric O2 Administration in Patients With Ischemic Stroke and Target Mismatch ProFile
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The main objective of the PROOF trial is to investigate efficacy and safety of normobaric
hyperoxygenation (NBHO) as a neuroprotective treatment in patients with acute ischemic stroke
due to large vessel occlusion likely to receive endovascular mechanical thrombectomy (TBY) in
a randomized controlled clinical phase IIb trial.